Poorly Differentiated Adenocarcinoma With Signet Ring Cells of the Gallbladder Producing a High Level of Alpha-fetoprotein: a Case Report

Completed

• Conditions: Gallbladder Cancer

• Registration Number: NCT05559229
• Lead Sponsor: junya mita

Brief Summary

Alpha-fetoprotein (AFP) can become elevated in hepatocellular carcinoma (HCC), yolk sac tumors and other malignant tumors of various organs. Herein, the investigator present a case of AFP-producing gallbladder carcinoma with signet ring cells successfully treated with laparoscopic whole-layer cholecystectomy.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-15
• Primary Completion: 2022-06-25
• Status Verified: 2022-09
• Study Completion: 2022-09-18
• Study First Submitted: 2022-09-19
• Study First Submitted QC: 2022-09-24
• Last Update Submitted: 2022-09-24
• Study First Posted: 2022-09-29
• Last Update Posted: 2022-09-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 1

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate the efficacy of measuring value of AFP for patients with gallbladder cancer.	1 year

Trial Locations

Locations (1)

oita Red Cross hospital; 🇯🇵 Ōita, Oita, Japan